Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma

European Journal of Surgical Oncology

Volumn 41, Issue 10, 2015, Pages 1386-1392

  Miura, J T ^a   Charlson, J ^a   Gamblin, T C ^a   Eastwood, D ^a   Banerjee, A ^a   Johnston, F M ^a   Turaga, K K ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Adjuvant; Chemotherapy; NCDB; Neoadjuvant; Retroperitoneal sarcoma; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROPERITONEAL SARCOMA; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; COHORT ANALYSIS; FIBROSARCOMA; LEIOMYOSARCOMA; LIPOSARCOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDY; SARCOMA; STATISTICAL MODEL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; FIBROSARCOMA; HUMANS; LEIOMYOSARCOMA; LIPOSARCOMA; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SARCOMA; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84943818360     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.07.014     Document Type: Article

References (28)

1. C.P. Raut, and P.W. Pisters Retroperitoneal sarcomas: combined-modality treatment approaches J Surg Oncol 94 2006 81 87
2. E. Stoeckle, J.M. Coindre, S. Bonvalot, and et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group Cancer 92 2001 359 368
3. P.J. Bremjit, R.L. Jones, X. Chai, and et al. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma Ann Surg Oncol 21 2014 2150 2158
4. J.J. Lewis, D. Leung, J.M. Woodruff, and et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution Ann Surg 228 1998 355 365
5. J.C. Yang, A.E. Chang, A.R. Baker, and et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity J Clin Oncol 16 1998 197 203
6. B. O'Sullivan, A.M. Davis, R. Turcotte, and et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial Lancet 359 2002 2235 2241
7. R.A. Zlotecki, T.S. Katz, C.G. Morris, and et al. Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience Am J Clin Oncol 28 2005 310 316
8. N. Pervaiz, N. Colterjohn, F. Farrokhyar, and et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma Cancer 113 2008 573 581
9. R.D. Issels, L.H. Lindner, J. Verweij, and et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study Lancet Oncol 11 2010 561 570
10. W.G. Kraybill, J. Harris, I.J. Spiro, and et al. Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: radiation Therapy Oncology Group Trial 9514 Cancer 116 2010 4613 4621
11. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
12. E. Bergstralh, and J. Kosanke Locally written SAS macros: greedy matching algorithm 2003 Mayo Clinic
13. J.F. Tierney, V. Mosseri, L.A. Stewart, and et al. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials Br J Cancer 72 1995 469 475
14. Anonymous Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration Lancet 350 1997 1647 1654
15. A. Italiano, F. Delva, S. Mathoulin-Pelissier, and et al. Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database Ann Oncol 21 2010 2436 2441
16. P.J. Woll, P. Reichardt, A. Le Cesne, and et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial Lancet Oncol 13 2012 1045 1054
17. V. Bramwell, J. Rouesse, W. Steward, and et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group J Clin Oncol 12 1994 1137 1149
18. E. Gortzak, A. Azzarelli, J. Buesa, and et al. A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma Eur J Cancer 37 2001 1096 1103
19. S. Singer, J.M. Corson, G.D. Demetri, and et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma Ann Surg 221 1995 185 195
20. R.L. Jones, C. Fisher, O. Al-Muderis, and et al. Differential sensitivity of liposarcoma subtypes to chemotherapy Eur J Cancer 41 2005 2853 2860
21. E.A. Perez, J.C. Gutierrez, F.L. Moffat, and et al. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location Ann Surg Oncol 14 2007 1114 1122
22. R.E. Brown, C.R. St Hill, Q.J. Greene, and et al. Impact of histology on survival in retroperitoneal sarcomas Am J Surg 202 2011 748 752 discussion 752-743
23. M. Toulmonde, S. Bonvalot, P. Méeus, and et al. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group Ann Oncol 25 2014 735 742
24. A. Gronchi, R. Miceli, E. Shurell, and et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets J Clin Oncol 31 2013 1649 1655
25. M.A. Dickson, W.D. Tap, M.L. Keohan, and et al. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma J Clin Oncol 31 2013 2024 2028
26. Group T-ARW Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group Ann Surg Oncol 22 2015 256 263
27. S. Bonvalot, R. Miceli, M. Berselli, and et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control Ann Surg Oncol 17 2010 1507 1514
28. A. Gronchi, R. Miceli, C. Colombo, and et al. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas Ann Oncol 23 2012 1067 1073